MARKETS / NASDAQ / NHP
NASDAQ · REAL ESTATE INVESTMENT TRUSTS · SMALL CAP

National Healthcare Properties, Inc. NHP

13 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$342.3M
▼ 3.3% vs FY2024
EPS · FY25
$-2.51
Dividend / sh · FY25
Payout · FY25
ROE · FY25
-9.0%
Net margin · FY25
-16.9%
Dividend coverage
-8.5×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 342.3M
Revenue, FY2025 · full 13-year series below
Revenue Net income
0.10.20.30.40.3-0.120132016201920222025
0.10.20.30.40.3-0.12016201920222025

The company lost 17 cents on every revenue dollar this year.

Per share
USD -2.51
Diluted EPS, FY2025
EPS Dividend
0.81.62.4-2.5120132016201920222025
0.81.62.4-2.512016201920222025

The dividend was paid in a year without profit.

Profitability
-9.0%
Return on equity, FY2025
ROE
0.250.50.751-9.0%20132016201920222025
0.250.50.751-9.0%2016201920222025
Operating margin1.0%
Net margin-16.9%
Return on assets-3.2%

Each USD of equity lost 9 cents this year.

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
−2.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+0.6%
−2.2%
+3.3%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.03B
Shares outstanding, FY2025
0.010.0320132016201920222025
0.090.032016201920222025
Change, 5 years+11.1%
Change, 10 years

The share count grew 11% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 1.7B
total assets, end of FY2025
Total assetsUSD 1.7B
EquityUSD 600.1M
CashUSD 57.6M
Gross debtUSD 367.6M
Net debtUSD 310.0M

Net debt stands at 52% of equity.

History
13 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
Revenue $B
0.3
0.4
0.3
0.3
0.3
0.4
0.4
0.4
0.3
0.3
0.2
0.1
0.0
Operating income $B
0.0
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
0.1
−0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
−0.0
0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
Net income $B
−0.1
−0.2
−0.1
−0.1
−0.1
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−2.51
−7.19
−3.04
−3.30
−0.82
−0.74
−0.88
−0.56
−0.47
−0.24
−0.49
−0.74
−0.10
Dividend / sh $
·
0.85
0.85
0.85
·
0.42
0.83
0.92
1.51
1.70
1.70
1.70
1.03
Payout %
·
·
·
−0
−0
−42
−58
−104
−180
−361
−159
−93
−590
ROE %
−9.0
−24.1
−7.7
−7.9
−8.6
−7.3
−7.6
−4.1
−3.0
−1.4
−2.5
−4.0
−0.1
Shares out B
0.03
0.03
0.03
0.03
0.10
0.09
0.09
0.09
0.09
0.09
0.09
0.08
0.01

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
26 of 26
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed